These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 20482389)

  • 1. Immune privilege of corneal allografts.
    Niederkorn JY; Larkin DF
    Ocul Immunol Inflamm; 2010 Jun; 18(3):162-71. PubMed ID: 20482389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immune privilege of corneal grafts.
    Niederkorn JY
    J Leukoc Biol; 2003 Aug; 74(2):167-71. PubMed ID: 12885932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
    Matoba AY; Peeler JS; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk corneal allografts and why they lose their immune privilege.
    Niederkorn JY
    Curr Opin Allergy Clin Immunol; 2010 Oct; 10(5):493-7. PubMed ID: 20689406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of T cell recruitment and chemokine-regulated intra-graft T cell motility patterns in corneal allograft rejection.
    Tan Y; Abdulreda MH; Cruz-Guilloty F; Cutrufello N; Shishido A; Martinez RE; Duffort S; Xia X; Echegaray-Mendez J; Levy RB; Berggren PO; Perez VL
    Am J Transplant; 2013 Jun; 13(6):1461-73. PubMed ID: 23679575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts.
    Hori J; Wang M; Miyashita M; Tanemoto K; Takahashi H; Takemori T; Okumura K; Yagita H; Azuma M
    J Immunol; 2006 Nov; 177(9):5928-35. PubMed ID: 17056517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corneal Allografts: Factors for and against Acceptance.
    Sakowska J; Glasner P; Zieliński M; Trzonkowski P; Glasner L
    J Immunol Res; 2021; 2021():5372090. PubMed ID: 34642632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immune privilege of corneal allografts.
    Niederkorn JY
    Transplantation; 1999 Jun; 67(12):1503-8. PubMed ID: 10401754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corneal transplantation and immune privilege.
    Niederkorn JY
    Int Rev Immunol; 2013 Feb; 32(1):57-67. PubMed ID: 23360158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severing corneal nerves in one eye induces sympathetic loss of immune privilege and promotes rejection of future corneal allografts placed in either eye.
    Paunicka KJ; Mellon J; Robertson D; Petroll M; Brown JR; Niederkorn JY
    Am J Transplant; 2015 Jun; 15(6):1490-501. PubMed ID: 25872977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradigm shifts in the role of CD4+ T cells in keratoplasty.
    Cunnusamy K; Chen PW; Niederkorn JY
    Discov Med; 2010 Nov; 10(54):452-61. PubMed ID: 21122477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
    Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.
    Stuart PM; Griffith TS; Usui N; Pepose J; Yu X; Ferguson TA
    J Clin Invest; 1997 Feb; 99(3):396-402. PubMed ID: 9022072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and immune privilege of corneal allografts.
    Hori J; Niederkorn JY
    Chem Immunol Allergy; 2007; 92():290-299. PubMed ID: 17264504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression.
    Beutelspacher SC; Pillai R; Watson MP; Tan PH; Tsang J; McClure MO; George AJ; Larkin DF
    Eur J Immunol; 2006 Mar; 36(3):690-700. PubMed ID: 16482510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypothesis of immune privilege of the cornea and pathophysiology of graft rejection].
    Trufanov SV; Subbot AM; Malozhen SA; Krakhmaleva DA
    Vestn Oftalmol; 2016; 132(5):117-124. PubMed ID: 28635736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of macrophage phenotype in rejected corneal allografts.
    Oh JY; Lee HJ; Ko AY; Ko JH; Kim MK; Wee WR
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7779-84. PubMed ID: 24159090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological disruption of antiangiogenic signals by recruited allospecific T cells leads to corneal allograft rejection.
    Tan Y; Cruz-Guilloty F; Medina-Mendez CA; Cutrufello NJ; Martinez RE; Urbieta M; Wilson D; Li Y; Perez VL
    J Immunol; 2012 Jun; 188(12):5962-9. PubMed ID: 22593618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J; Kurimoto I; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective Role of ICOS and ICOS Ligand in Corneal Transplantation and in Maintenance of Immune Privilege.
    Kunishige T; Taniguchi H; Terada M; Akiba H; Yagita H; Abe R; Hori J
    Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6815-6823. PubMed ID: 28002569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.